| BS08011 |
Breast infiltrating ductal carcinoma tissue array, 22 cases 63 cores, replaced by BR727
|
US Biomax |
|
160.00€ |
|
Pub |
| BR2085a |
High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c.
|
US Biomax |
|
456.00€ |
|
Pub |
| T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| BR2085b |
High density (188 cases 208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast
|
US Biomax |
|
456.00€ |
|
Pub |
| BR1004 |
Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010
|
US Biomax |
|
314.00€ |
|
Pub |
| BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95
|
US Biomax |
|
456.00€ |
|
Pub |
| BR245 |
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246
|
US Biomax |
|
88.00€ |
|
Pub |
| BC08013 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014
|
US Biomax |
|
160.00€ |
|
Pub |
| BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| BR1504 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BRC491 |
Human breast invasive ductal carcinoma (IDC) tissue array, non overlapping with BRC711, 49 cases 49 cores
|
US Biomax |
|
142.00€ |
|
Pub |
| BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| BR805 |
Breast infiltrating lobular carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243
|
US Biomax |
|
99.00€ |
|
Pub |
| BC08016 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803
|
US Biomax |
|
160.00€ |
|
Pub |
| BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax |
|
266.00€ |
|
Pub |
| BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax |
|
99.00€ |
|
Pub |
| BC08015 |
Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728
|
US Biomax |
|
160.00€ |
|
Pub |
| BR1921 |
High density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
| BR486 |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| BR1001 |
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases 100 cores, replaced by BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
| BR701 |
Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962
|
US Biomax |
|
231.00€ |
|
Pub |
| BC08032 |
Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC12012 |
Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802
|
US Biomax |
|
231.00€ |
|
Pub |
| BC06022 |
Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by RE722
|
US Biomax |
|
160.00€ |
|
Pub |
| BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax |
|
189.00€ |
|
Pub |
| BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212
|
US Biomax |
|
266.00€ |
|
Pub |
| BR8010 |
Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| PR802 |
Prostate carcinoma tissue array, 80 cases 80 cores, no overlaps with PR801, replaced by PR8010
|
US Biomax |
|
231.00€ |
|
Pub |
| BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723
|
US Biomax |
|
160.00€ |
|
Pub |
| BN08013 |
Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801
|
US Biomax |
|
160.00€ |
|
Pub |
| BC08023 |
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084
|
US Biomax |
|
88.00€ |
|
Pub |
| BC03021 |
Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803
|
US Biomax |
|
231.00€ |
|
Pub |
| BR244 |
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245
|
US Biomax |
|
88.00€ |
|
Pub |
| CR601 |
Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602
|
US Biomax |
|
231.00€ |
|
Pub |
| BS03011 |
Hepatocellular carcinoma tissue array, 21 cases 63 cores, replaced by LV804
|
US Biomax |
|
160.00€ |
|
Pub |
| BC19012 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808
|
US Biomax |
|
231.00€ |
|
Pub |
| BC050112 |
Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726
|
US Biomax |
|
231.00€ |
|
Pub |
| BR961 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962
|
US Biomax |
|
0.00€ |
|
Pub |
| BR801 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804
|
US Biomax |
|
231.00€ |
|
Pub |
| BC04016 |
Lung carcinoma tissue array, 72 cases 72 cores, replaced by LC726
|
US Biomax |
|
160.00€ |
|
Pub |
| BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021
|
US Biomax |
|
160.00€ |
|
Pub |
| T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085
|
US Biomax |
|
88.00€ |
|
Pub |
| BC03013 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723
|
US Biomax |
|
160.00€ |
|
Pub |
| BR2001 |
Breast cancer high density tissue array, 196 cases 200 cores, replaced by BR2086
|
US Biomax |
|
456.00€ |
|
Pub |
| BC07012 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015
|
US Biomax |
|
160.00€ |
|
Pub |
| BR802 |
Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases 80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b
|
US Biomax |
|
231.00€ |
|
Pub |
| BC05011 |
Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804
|
US Biomax |
|
231.00€ |
|
Pub |
| BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax |
|
429.00€ |
|
Pub |
| FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a
|
US Biomax |
|
293.00€ |
|
Pub |
| BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015
|
US Biomax |
|
231.00€ |
|
Pub |
| BC11011 |
Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a
|
US Biomax |
|
88.00€ |
|
Pub |
| BS04031 |
Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724
|
US Biomax |
|
160.00€ |
|
Pub |
| BC19017 |
Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809
|
US Biomax |
|
160.00€ |
|
Pub |
| BR243 |
Breast cancer and adjacent normal tissue array, 6 cases 24 cores, replaced by BR243a
|
US Biomax |
|
88.00€ |
|
Pub |
| BC03011 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010
|
US Biomax |
|
160.00€ |
|
Pub |
| BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax |
|
296.00€ |
|
Pub |
| BR809 |
Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013
|
US Biomax |
|
160.00€ |
|
Pub |
| ES1201 |
Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202
|
US Biomax |
|
278.00€ |
|
Pub |
| T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088
|
US Biomax |
|
88.00€ |
|
Pub |
| BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456.00€ |
|
Pub |
| BRM481 |
Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| IC00011 |
Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases 80 cores, replaced by IC00011b
|
US Biomax |
|
231.00€ |
|
Pub |
| BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807
|
US Biomax |
|
160.00€ |
|
Pub |
| BS04011 |
Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808
|
US Biomax |
|
160.00€ |
|
Pub |
| BR242 |
Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores, replaced by BR244
|
US Biomax |
|
88.00€ |
|
Pub |
| BR1502 |
Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503
|
US Biomax |
|
278.00€ |
|
Pub |
| BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807
|
US Biomax |
|
231.00€ |
|
Pub |
| BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
| BR8012 |
Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014
|
US Biomax |
|
231.00€ |
|
Pub |
| BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
| BR808 |
Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018
|
US Biomax |
|
231.00€ |
|
Pub |
| BC21011 |
Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014
|
US Biomax |
|
231.00€ |
|
Pub |
| BRC711 |
Human breast invasive ductal cancer tissue array, non overlapping with BRC491, 71 cases 72 cores
|
US Biomax |
|
142.00€ |
|
Pub |
| BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120
|
US Biomax |
|
278.00€ |
|
Pub |
| BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723
|
US Biomax |
|
160.00€ |
|
Pub |
| BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a
|
US Biomax |
|
88.00€ |
|
Pub |
| BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811
|
US Biomax |
|
160.00€ |
|
Pub |
| BR481 |
Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BS03014 |
Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809
|
US Biomax |
|
160.00€ |
|
Pub |
| BC08014 |
Breast cancer (multiple types of breast cancer) tissue array, 63 cases 63 cores, replaced by BR8018
|
US Biomax |
|
160.00€ |
|
Pub |
| CO1002 |
Colon and rectum carcinoma and normal tissue array, 73 cases 100 cores, replaced by CO1002b
|
US Biomax |
|
278.00€ |
|
Pub |
| BR807 |
Medullary carcinoma of breast tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| BC01011 |
Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721
|
US Biomax |
|
160.00€ |
|
Pub |
| BR20810 |
Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BS36011 |
Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases 75 cores, replaced by OS803
|
US Biomax |
|
266.00€ |
|
Pub |
| BC01071 |
Carcinoma of stomach, liver and rectum tissue array, 45 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| LVC2281 |
Liver cancer high density tissue array, 228 cases 228 cores, replaced by LV2161
|
US Biomax |
|
403.00€ |
|
Pub |
| CO802 |
Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801
|
US Biomax |
|
189.00€ |
|
Pub |
| FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
278.00€ |
|
Pub |
| PR631 |
Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores
|
US Biomax |
|
266.00€ |
|
Pub |
| T194 |
Prostate cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T195
|
US Biomax |
|
88.00€ |
|
Pub |
| BR20825 |
Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| T083 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BO242 |
Human normal bone tissue array, 12 cases 24 cores, replaced by BO243
|
US Biomax |
|
100.00€ |
|
Pub |
| BS02021 |
Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR8016 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| KD482 |
Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001
|
US Biomax |
|
456.00€ |
|
Pub |
| PA802 |
Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805
|
US Biomax |
|
266.00€ |
|
Pub |
| LN801 |
Normal lymphatic (lymph node, thymus, spleen, tonsil and appendix) tissue array, 80 cases 80 cores, replaced by LN802
|
US Biomax |
|
231.00€ |
|
Pub |
| BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b
|
US Biomax |
|
231.00€ |
|
Pub |
| BS05031 |
Colon adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by CO724
|
US Biomax |
|
160.00€ |
|
Pub |
| NHL802 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL801, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
| T171 |
Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases 24 cores, replaced by T174
|
US Biomax |
|
88.00€ |
|
Pub |
| MC616 |
High density lung, breast, brain and colon cancer array, with stage, grade and normal tissue array, 308 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
| BC07014 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR20815 |
Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LC805 |
Lung large cell carcinoma and bronchioloalveolar carcinoma tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC02012 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed
|
US Biomax |
|
742.00€ |
|
Pub |
| LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011
|
US Biomax |
|
231.00€ |
|
Pub |
| BR725 |
Breast cancer, adjacent and adjacent normal tissue array, 68 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC09012 |
Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR2083 |
High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| SK243 |
Age grouped female skin tissue array, 12 cases 24 cores, replaced by SK244
|
US Biomax |
|
231.00€ |
|
Pub |
| T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| BC04012 |
Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BS03013 |
Hepatocellular carcinoma tissue array, 22 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| FDA995 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997
|
US Biomax |
|
278.00€ |
|
Pub |
| PR952 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR953
|
US Biomax |
|
314.00€ |
|
Pub |
| ME1003 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004
|
US Biomax |
|
266.00€ |
|
Pub |
| BC19013 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR2161 |
Breast cancer tissue array, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
| BC05012 |
Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores.
|
US Biomax |
|
231.00€ |
|
Pub |
| BS06041 |
Rectum adenocarcinoma (grade III) tissue array, 21 cases 63 cores, replaced by RE724
|
US Biomax |
|
160.00€ |
|
Pub |
| TP241 |
Top 4 types of cancer (colon, breast, lung and prostate) tissue array, including TNM and pathology grade, 12 cases 24 cores
|
US Biomax |
|
99.00€ |
|
Pub |
| NPC481 |
Nasopharyngeal carcinoma tissue array, 48 cases 49 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| BR962 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701
|
US Biomax |
|
231.00€ |
|
Pub |
| BC34011 |
Head and neck squamous cell carcinoma tissue array, 24 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR480 |
Breast disease spectrum tissue array progression array, 48 cases 48 cores
|
US Biomax |
|
314.00€ |
|
Pub |
| LV809 |
Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014
|
US Biomax |
|
231.00€ |
|
Pub |
| BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963
|
US Biomax |
|
231.00€ |
|
Pub |
| BR485 |
Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases 96 cores
|
US Biomax |
|
397.00€ |
|
Pub |
| LV1501 |
Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| BR2082 |
Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
| BC11012 |
Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR20834 |
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ES802 |
Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801
|
US Biomax |
|
231.00€ |
|
Pub |
| SK483 |
Multiple skin squamous cell carcinoma tissue array with normal tissues control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| OV2084 |
Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814
|
US Biomax |
|
456.00€ |
|
Pub |
| BC04021 |
Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR082 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores
|
US Biomax |
|
112.00€ |
|
Pub |
| BC00014 |
Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631
|
US Biomax |
|
160.00€ |
|
Pub |
| BR806 |
Breast hyperplasia tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| CR1001 |
Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| LV631 |
Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
| PE801 |
Penile (penis) carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| LC721 |
Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011
|
US Biomax |
|
231.00€ |
|
Pub |
| BRC1501 |
Breast cancer mid density tissue array, non overlapping with either BRC1502 or BRC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016
|
US Biomax |
|
231.00€ |
|
Pub |
| LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001
|
US Biomax |
|
231.00€ |
|
Pub |
| BR641 |
Breast cancer tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
| FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
| BR20824 |
Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BS01042 |
Stomach adenocarcinoma (grade III) tissue array, 22 cases 63 cores, replaced by ST723
|
US Biomax |
|
160.00€ |
|
Pub |
| BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014
|
US Biomax |
|
231.00€ |
|
Pub |
| FDA902-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
| KD481 |
Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a
|
US Biomax |
|
456.00€ |
|
Pub |
| PA801 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802
|
US Biomax |
|
231.00€ |
|
Pub |
| SK802 |
Skin squamous cell carcinoma (SCC) tissue array, 80 cases 80 cores, no overlaps with SK801
|
US Biomax |
|
231.00€ |
|
Pub |
| BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR1003 |
Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data
|
US Biomax |
|
266.00€ |
|
Pub |
| BS05021 |
Colon adenocarcinoma (grade I) tissue array, 23 cases 63 cores, replaced by CO723
|
US Biomax |
|
160.00€ |
|
Pub |
| LC482 |
Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status
|
US Biomax |
|
160.00€ |
|
Pub |
| BN01011 |
Normal stomach tissue (multi sites) array, 21 cases 63 cores, replaced by BN01011b
|
US Biomax |
|
160.00€ |
|
Pub |
| BR812 |
Breast cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, with TNM data
|
US Biomax |
|
231.00€ |
|
Pub |
| PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
114.00€ |
|
Pub |
| BC06011 |
Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR208 |
High density, multiple breast cancer (1 3 grade) and normal breast tissue array, 70 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BS26011 |
Osteosarcoma tissue array, 32 cases 63 cores, replaced by OS804
|
US Biomax |
|
231.00€ |
|
Pub |
| OV804 |
Ovarian metastatic carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax |
|
160.00€ |
|
Pub |
| BR20814 |
Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ES1501 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| LC803 |
Lung carcinoma (multi tissue combined panel, 80 cases 80 cores) tissue array
|
US Biomax |
|
231.00€ |
|
Pub |
| BRD181 |
Breast disease tissue array, 18 cases 18 cores
|
US Biomax |
|
118.00€ |
|
Pub |
| BR724 |
Breast cancer, adjacent and adjacent normal tissue array, 66 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20829 |
Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax |
|
231.00€ |
|
Pub |
| LC991 |
Lung squamous cell carcinoma (grade I III) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
| BR802b |
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases 80cores, replacing BR802
|
US Biomax |
|
266.00€ |
|
Pub |
| FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995
|
US Biomax |
|
314.00€ |
|
Pub |
| PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
| KD486 |
Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| ES961 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores
|
US Biomax |
|
336.00€ |
|
Pub |
| BR1007 |
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BS06031 |
Rectum adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by RE723
|
US Biomax |
|
160.00€ |
|
Pub |
| NPC111 |
Nasopharyngeal carcinoma tissue array, 11 cases 11 cores
|
US Biomax |
|
106.00€ |
|
Pub |
| BN05011 |
Normal colon tissue (multi site) array, 23 cases 63 cores, replaced by BN05014
|
US Biomax |
|
160.00€ |
|
Pub |
| FMC405 |
Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
| T381 |
Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385
|
US Biomax |
|
88.00€ |
|
Pub |
| ME801 |
Malignant melanoma tissue array, 80 cases 80 cores, replaced by ME804
|
US Biomax |
|
231.00€ |
|
Pub |
| ST802 |
Stomach carcinoma (multi tissue combined panel) tissue array, 78 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR484 |
Breast cancer tissue array, including TNM and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| BR20819 |
Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC02023 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54cores, replaced by ES722
|
US Biomax |
|
160.00€ |
|
Pub |
| BRN801 |
Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013
|
US Biomax |
|
231.00€ |
|
Pub |
| LC2081 |
Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information
|
US Biomax |
|
456.00€ |
|
Pub |
| MC962 |
Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores
|
US Biomax |
|
0.00€ |
|
Pub |
| BR20833 |
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| IC03001 |
Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805
|
US Biomax |
|
231.00€ |
|
Pub |
| BR042a |
Breast cancer tissue array, including TNM and pathology grade, 4 cases 4 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| BS04041 |
Lung squamous cell carcinoma (grade II) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti-
|
US Biomax |
|
296.00€ |
|
Pub |
| BS17015 |
Brain glioma tissue array, 63 cases 63 cores, replaced by GL803
|
US Biomax |
|
231.00€ |
|
Pub |
| LC641 |
Non small cell lung carcinoma (NSCLC) tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
| OM601 |
Metastatic carcinoma of epiploon tissue array, 60 cases 60 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BN07012 |
Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803
|
US Biomax |
|
160.00€ |
|
Pub |
| BRC1021 |
Breast cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b
|
US Biomax |
|
88.00€ |
|
Pub |
| BN113 |
Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| BRC481 |
Breast cancer and normal tissue array, 16 cases 48 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| LC1005 |
Lung carcinoma progression tissue array, 77 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| ST807 |
Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR6161 |
High density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
| CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax |
|
266.00€ |
|
Pub |
| FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
| T192 |
Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195
|
US Biomax |
|
88.00€ |
|
Pub |
| BR20823 |
Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| PA207 |
High density (69 cases 207 cores), multiple pancreatic cancer (1 3 grade) and normal pancreatic tissue array, replaced by PA2072
|
US Biomax |
|
456.00€ |
|
Pub |
| UT803 |
Endometrioid carcinoma, adjacent and normal tissue array, with grade and stage information, 40 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012
|
US Biomax |
|
231.00€ |
|
Pub |
| KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| LM802 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
| SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801
|
US Biomax |
|
321.00€ |
|
Pub |
| LC481 |
Tissue array of lung carcinoma and matched adjacent tissue, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC001111 |
Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601
|
US Biomax |
|
231.00€ |
|
Pub |
| BR811 |
Breast cancer tissue array with normal tissues from autopsy, 80 cases 80 cores, with grade and stage data
|
US Biomax |
|
231.00€ |
|
Pub |
| KD951 |
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| MC5001 |
High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002
|
US Biomax |
|
634.00€ |
|
Pub |
| BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
| BR20813 |
Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| HER2 |
Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
114.00€ |
|
Pub |
| LC802 |
Lung small cell carcinoma tissue array (40 cases 80 cores)
|
US Biomax |
|
266.00€ |
|
Pub |
| BRC962 |
Breast cancer and normal tissue array, non overlapping with BRC961, with TNM data, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| BR723 |
Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases 72 cores
|
US Biomax |
|
314.00€ |
|
Pub |
| CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115
|
US Biomax |
|
266.00€ |
|
Pub |
| BR20828 |
Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| PA241 |
Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241b
|
US Biomax |
|
100.00€ |
|
Pub |
| T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084
|
US Biomax |
|
88.00€ |
|
Pub |
| GI961 |
GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| ME1001 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, replaced by ME1003, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BR2089 |
Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| MC242 |
Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245
|
US Biomax |
|
88.00€ |
|
Pub |
| BR1006 |
Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BN04011 |
Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725
|
US Biomax |
|
160.00€ |
|
Pub |
| LV802 |
Liver carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with LV801
|
US Biomax |
|
189.00€ |
|
Pub |
| BC30011 |
Heart tissue array, 13 cases 34 cores, replaced by BC30013
|
US Biomax |
|
231.00€ |
|
Pub |
| BR247 |
Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores, 2 sections sllide
|
US Biomax |
|
189.00€ |
|
Pub |
| BR483 |
Multiple breast cancer tissue array with normal tissues from autopsy, with TNM, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores
|
US Biomax |
|
558.00€ |
|
Pub |
| BR20818 |
Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LC808 |
Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011
|
US Biomax |
|
231.00€ |
|
Pub |
| OV1001 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005
|
US Biomax |
|
231.00€ |
|
Pub |
| BC02022 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| MC961 |
Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20832 |
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011
|
US Biomax |
|
321.00€ |
|
Pub |
| T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| BC04015 |
Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC00012 |
Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801
|
US Biomax |
|
160.00€ |
|
Pub |
| BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
| LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
| CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax |
|
81.00€ |
|
Pub |
| LP803 |
Laryngeal squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502
|
US Biomax |
|
278.00€ |
|
Pub |
| BS17011 |
Brain glioblastoma tissue array, 21 cases 63 cores, replaced by GL811
|
US Biomax |
|
231.00€ |
|
Pub |
| GL802 |
Glioblastoma (grade IV) tissue array, 40 cases 80 cores, replaced by GL805
|
US Biomax |
|
231.00€ |
|
Pub |
| BC00119 |
Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483
|
US Biomax |
|
160.00€ |
|
Pub |
| BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
| LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| BRC2281 |
High density breast cancer tissue array, 228 cases 228 cores
|
US Biomax |
|
0.00€ |
|
Pub |
| LC1004 |
Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR602 |
Breast tumor and normal tissue array, with TNM data, 25 cases 60 cores
|
US Biomax |
|
0.00€ |
|
Pub |
| FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies.
|
US Biomax |
|
278.00€ |
|
Pub |
| BR20822 |
Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
| UT802 |
Uteral cancer (multi types of uterine carcinomas and diseases) tissue array, 80 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BS01032 |
Stomach adenocarcinoma (grade II) tissue array, 63 cases 63 cores, replaced by ST808
|
US Biomax |
|
160.00€ |
|
Pub |
| BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806
|
US Biomax |
|
266.00€ |
|
Pub |
| BR8013 |
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429.00€ |
|
Pub |
| PR804 |
Hyperplasia and carcinoma of prostate tissue array, 80 cases 80 cores, with grade and Gleason score information
|
US Biomax |
|
266.00€ |
|
Pub |
| SK801 |
Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases 73 cores, replaced by SK801b
|
US Biomax |
|
278.00€ |
|
Pub |
| BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BS04111 |
Lung small cell carcinoma tissue array, 33 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| KD811 |
Renal carcinoma and normal tissue array, with TNM, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| CO482 |
Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR1922 |
Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BS17018 |
Brain glioblastoma tissue array, 33 cases 63 cores, replaced by GL805
|
US Biomax |
|
231.00€ |
|
Pub |
| T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045
|
US Biomax |
|
88.00€ |
|
Pub |
| BR20812 |
Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LC801 |
Lung carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| BRC961 |
Breast cancer array with normal and other non malignant breast tissues, non overlapping with BRC962, with AR ER PR Her 2(neu) IHC results, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR722 |
Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages
|
US Biomax |
|
231.00€ |
|
Pub |
| FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2
|
US Biomax |
|
278.00€ |
|
Pub |
| BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BR20827 |
Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LC951 |
Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores
|
US Biomax |
|
278.00€ |
|
Pub |
| BS02041 |
Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| GI481 |
GI cancer (gastric, colon and rectal carcinoma) tissue array, 24 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BR2088 |
Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| MC241 |
Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244
|
US Biomax |
|
88.00€ |
|
Pub |
| BN03011 |
Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801
|
US Biomax |
|
160.00€ |
|
Pub |
| FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
| LV8013 |
Hepatocellular carcinoma tissue array, including TNM, pathology grade, HBV and HCV infection information, 40 cases 80 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| MC541 |
Multiple organ, diseased tissue array (54 cases 54 cores, 18 types of cancers), replaced by MC542
|
US Biomax |
|
160.00€ |
|
Pub |
| BR482 |
Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases 48 cores, with stage and grade info
|
US Biomax |
|
160.00€ |
|
Pub |
| BR20817 |
Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ES2001 |
Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores
|
US Biomax |
|
516.00€ |
|
Pub |
| BC02021 |
Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| FRA901-2 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
| LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011
|
US Biomax |
|
231.00€ |
|
Pub |
| PR801 |
Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases 80 cores, replaced by PR803
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20831 |
Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085
|
US Biomax |
|
88.00€ |
|
Pub |
| BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| FDA998 |
FDA normal organ tissue array of human, 47 cases 99 cores, replaced by FDA999
|
US Biomax |
|
314.00€ |
|
Pub |
| PR954 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR955
|
US Biomax |
|
456.00€ |
|
Pub |
| KD802 |
Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC19015 |
Prostate carcinoma tissue array, 9 cases 27 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| NPC962 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC961, 96 cases 96 cores
|
US Biomax |
|
308.00€ |
|
Pub |
| BC00116 |
Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T385 |
Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386
|
US Biomax |
|
88.00€ |
|
Pub |
| BRC1503 |
Breast cancer mid density tissue array, non overlapping with BRC1501 or BRC1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| LC1002 |
Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20821 |
Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002
|
US Biomax |
|
321.00€ |
|
Pub |
| MO32011 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replaced by MO1002
|
US Biomax |
|
189.00€ |
|
Pub |
| CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| MCN601 |
Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20836 |
Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BS04102 |
Large cell carcinoma of lung tissue array, 21 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| LC242 |
Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| NHL481 |
Lymphoma tissue array, 48 cases 48 cores, replaced by NHL482
|
US Biomax |
|
189.00€ |
|
Pub |
| BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| SM801 |
Small intestine carcinoma and normal tissue array, 77 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| GL805 |
Glioblastoma multiforme (GBM) tissue array, 40 cases 80 cores, replaced by GL806
|
US Biomax |
|
266.00€ |
|
Pub |
| BR20811 |
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LC727 |
Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BN116 |
Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129
|
US Biomax |
|
189.00€ |
|
Pub |
| CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| BR721 |
Breast cancer tissue array with self matching adjacent tissue and normal tissue, 24 cases 72 cores, no overlaps with other BR TMAs
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20826 |
Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| T084 |
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082
|
US Biomax |
|
88.00€ |
|
Pub |
| BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BO243 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replaced by BO244
|
US Biomax |
|
88.00€ |
|
Pub |
| LC2082 |
Multiple lung carcinoma and normal tissue array, 70 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BR8017 |
Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BC15012 |
Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR2087 |
Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BS05041 |
Colon adenocarcinoma (grade III) tissue array, 23 cases 63 cores, replaced by CO725
|
US Biomax |
|
189.00€ |
|
Pub |
| TMA2081 |
High density (156 cases 208 cores) tissue array of normal colon, prostate and breast tissue
|
US Biomax |
|
456.00€ |
|
Pub |
| OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011
|
US Biomax |
|
231.00€ |
|
Pub |
| PR241 |
Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243
|
US Biomax |
|
88.00€ |
|
Pub |
| BR20816 |
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013
|
US Biomax |
|
231.00€ |
|
Pub |
| BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| FRA901-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
| LC1921 |
High density non small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BR726 |
Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC10021 |
Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20830 |
Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ES801 |
Esophagus cancer, with matched normal adjacent tissue array, 40 cases 80 cores, replaced by ES8010
|
US Biomax |
|
231.00€ |
|
Pub |
| T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| BC04013 |
Non small cell lung carcinoma tissue array, 63 cases 63 core, replaced by LC806
|
US Biomax |
|
160.00€ |
|
Pub |
| LY802 |
Lymph node metastatic squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601
|
US Biomax |
|
278.00€ |
|
Pub |
| BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
| FDA997 |
FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998
|
US Biomax |
|
314.00€ |
|
Pub |
| PR953 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR954
|
US Biomax |
|
456.00€ |
|
Pub |
| BC19014 |
Prostate carcinoma tissue array, 31 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR241 |
Breast cancer test tissue array with self matched or unmatched normal adjacent tissues, 6 cases 24 cores.
|
US Biomax |
|
88.00€ |
|
Pub |
| BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722
|
US Biomax |
|
231.00€ |
|
Pub |
| BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| TP242 |
Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| NPC961 |
Nasopharyngeal carcinoma tissue array, non overlapping with NPC962, >50 cases 96 cores
|
US Biomax |
|
344.00€ |
|
Pub |
| BC00115 |
Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802
|
US Biomax |
|
231.00€ |
|
Pub |
| BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962
|
US Biomax |
|
314.00€ |
|
Pub |
| FMC406 |
Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
| BN08111 |
Breast hyperplasia and normal tissue array, 10 cases 30 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BRC1502 |
Breast cancer mid density tissue array, non overlapping with either BRC1501 or BRC1503, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
| T391 |
Mesothelioma test tissue array, with normal mesothelium tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T392
|
US Biomax |
|
88.00€ |
|
Pub |
| OV951 |
Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores,
|
US Biomax |
|
456.00€ |
|
Pub |
| BR20820 |
Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| HN482 |
Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483
|
US Biomax |
|
160.00€ |
|
Pub |
| BR8011 |
Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases 80 cores
|
US Biomax |
|
314.00€ |
|
Pub |
| CO812 |
Colon carcinoma and normal tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BR20835 |
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| BC04022 |
Non small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| LV721 |
Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702
|
US Biomax |
|
231.00€ |
|
Pub |
| BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
|
US Biomax |
|
296.00€ |
|
Pub |
| T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044
|
US Biomax |
|
88.00€ |
|
Pub |
| ES1001 |
Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| GL808 |
Brain tumor tissue array, with matched adjacent normal tissue, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
| T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| UNC241 |
Universal control tissue array, used for screening of more than 90% routine IHC markers, 12 cases 24 cores
|
US Biomax |
|
77.00€ |
|
Pub |
| OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
| BN115 |
Multiple organ normal tissue array, 46 cases 46 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| CR483 |
Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with TNM data
|
US Biomax |
|
160.00€ |
|
Pub |
| FMS151 |
Brains of multiple species frozen tissue array, 14 cases 15 cores
|
US Biomax |
|
293.00€ |
|
Pub |
| LC1007 |
Lung tuberculosis tissue array with normal tissue, 48 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| ST810 |
Stomach cancer with matched lymph node metastasis tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T433 |
Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| MNO961 |
35 types of normal human tissue array, 90 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| AMS541 |
Mouse(FBV strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| KD20810 |
Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| RA162 |
Multiple organs normal tissue array of rat, 8 cases 16 cores
|
US Biomax |
|
189.00€ |
|
Pub |
| LV20810 |
Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| SO807 |
Interstitialoma of gastrointestinal tract tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed
|
US Biomax |
|
320.00€ |
|
Pub |
| OVC241 |
Ovary cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
166.00€ |
|
Pub |
| CO1501 |
Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
| ES482 |
Multiple esophagus cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with grade and stage data
|
US Biomax |
|
160.00€ |
|
Pub |
| PA207b |
High density (69 cases 207 cores), multiple pancreatic cancer (I 4 grade) and normal pancreatic tissue array BLOCK
|
US Biomax |
|
40 981.00€ |
|
Pub |
| HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
| LC816 |
Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| SFT961 |
Soft tissue tumor tissue array, 48 cases 96 cores
|
US Biomax |
|
225.00€ |
|
Pub |
| UTE601 |
Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases 60 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| OV1921 |
Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| GA801 |
Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
123.00€ |
|
Pub |
| LC20816 |
Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| LY2086 |
Lymphoma tumor tissue array, 208 cases 208 cores
|
US Biomax |
|
633.00€ |
|
Pub |
| T0011 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| TH801 |
Thyroid cancer tissue array, with matched or unmatched adjacent normal tissue, 68 cases 80 cores, no overlaps with TH802
|
US Biomax |
|
231.00€ |
|
Pub |
| MS801 |
Mesothelioma tissue array with normal mesothelium, with stage and TNM data, 40 cases 80 cores
|
US Biomax |
|
397.00€ |
|
Pub |
| BL804 |
Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| CO992 |
Colorectal (colon and rectum) cancer with matched lymph node metastasis and normal adjacent tissue array, 43 cases 99 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| PR807 |
Prostate cancer, hyperplasia and normal tissue array, with stage (Gleason Scores) and grade info, 79 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
| RE641 |
Rectum cancer tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
| LV244 |
Liver cancer tissue array, with stage and grade info, 8 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| ST2001 |
Stomach cancer high density (200 cases 200 cores) tissue array, including TNM and pathology grade
|
US Biomax |
|
397.00€ |
|
Pub |
| T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| CO2087 |
Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| ES808 |
Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| SK803 |
Skin basal cell cancer (BCC) and benign nevus tissue array, 52 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| T104 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| MBN481 |
Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
| OV2161 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 216 cases 216 cores
|
US Biomax |
|
633.00€ |
|
Pub |
| GL241 |
Multiple brain cancer tissue array with self matching normal adjacent tissues, 10 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| LC483 |
Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| T014 |
Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| TMA2001 |
Multiple organ cancer with normal tissue array, with TNM data, 180 cases 200 cores
|
US Biomax |
|
397.00€ |
|
Pub |
| BC00112 |
Multiple organ paired normal and cancer (8 types) tissue array, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BN01011b |
Normal stomach tissue array, 24 cases 72 cores, replacing BN01011
|
US Biomax |
|
277.00€ |
|
Pub |
| CR2081 |
High density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
| KD991 |
Kidney cancer tissue array with matched cancer adjacent and cancer adjacent normal tissue, 33 cases 99 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| REC1503 |
Rectum cancer mid density tissue array, non overlapping with REC1501 or REC1502, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
| LV8011 |
Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| ST723 |
Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042
|
US Biomax |
|
231.00€ |
|
Pub |
| T321 |
Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
| ME481 |
Multiple melanoma tissue array with normal skin tissues, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
| BC24011 |
Soft tissue tumor (multi tissue combined panel) tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
| CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
| LUC482 |
Lung cancer and normal tissue array, non overlapping with LUC481, 16 cases 48 cores
|
US Biomax |
|
166.00€ |
|
Pub |
| SO2081 |
Muscle disease spectrum (smooth muscle and striated muscle cancer progression) tissue array, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
| T144 |
Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
| MC5003 |
High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002
|
US Biomax |
|
634.00€ |
|
Pub |
| OV8010 |
Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
